Page last updated: 2024-10-30

edaravone and Arterial Diseases, Cerebral

edaravone has been researched along with Arterial Diseases, Cerebral in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with edaravone can prevent occurrence of cerebral hyperperfusion after CEA."1.32Pretreatment with the free radical scavenger edaravone prevents cerebral hyperperfusion after carotid endarterectomy. ( Endo, H; Fukuda, T; Inoue, T; Kobayashi, M; Ogasawara, K; Ogawa, A, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogasawara, K1
Inoue, T1
Kobayashi, M1
Endo, H1
Fukuda, T1
Ogawa, A1
Niiya, Y1
Abumiya, T1
Shichinohe, H1
Kuroda, S1
Kikuchi, S1
Ieko, M1
Yamagishi, S1
Takeuchi, M1
Sato, T1
Iwasaki, Y1

Other Studies

2 other studies available for edaravone and Arterial Diseases, Cerebral

ArticleYear
Pretreatment with the free radical scavenger edaravone prevents cerebral hyperperfusion after carotid endarterectomy.
    Neurosurgery, 2004, Volume: 55, Issue:5

    Topics: Aged; Antipyrine; Brain; Carotid Artery, Internal; Carotid Stenosis; Cerebral Arterial Diseases; Cer

2004
Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species.
    Brain research, 2006, Sep-07, Volume: 1108, Issue:1

    Topics: Animals; Antipyrine; Aorta; Brain; Cattle; Cell Line; Cerebral Arterial Diseases; Cerebral Arteries;

2006